Annual Document
Annual Document according German Securities Prospectus Act, s. 10
Fiscal year 2012/2013
Nach § 10 des am 1. Juli 2005 in Kraft getretenen Wertpapierprospektgesetzes (WpPG) sind börsennotierte Unternehmen verpflichtet, mindestens einmal jährlich bestimmte kapitalmarktrelevante Informationen, die sie in den vorausgegangenen zwölf Monaten veröffentlicht oder dem Publikum zur Verfügung gestellt haben, in einem Dokument zusammenzufassen und dem Publikum zugänglich zu machen (sog. Jährliches Dokument).
Finanzberichte
- Aug 14, 2012 : Financial Report Q1 (April 1st - June 30, 2012) (PDF, 172KB)
- Nov 14, 2012 : Financial Report Q2 (July 1st - September 30 2012) (PDF, 143KB)
Ad-hoc-Mitteilungen gem. § 15 WpHG
-
Oct 17, 2012:
SYGNIS Pharma AG announces appointment of chairman of Management Board
-
Mar 25, 2013:
SYGNIS announces Management Board changes
-
Mar 04, 2013:
SYGNIS Pharma AG secures further financial resources with shareholder loan
-
Dec 20, 2012:
SYGNIS announces the adaptation of its organisation to the new business activity
-
Oct 17, 2012:
SYGNIS Pharma AG announces changes in Management Board
-
Sep 24, 2012:
SYGNIS Pharma AG / Genetrix Life Sciences, A.B., and Genetrix, S.L., Granted Exemption from Mandatory Tender Offer to Shareholders of SYGNIS Pharma AG
-
Sep 06, 2012:
SYGNIS announces intended changes in the Supervisory Board
-
Jul 31, 2012:
SYGNIS Announces Prolongation of Standby Equity Distribution Agreement
-
Jul 18, 2012:
SYGNIS Announces Proposed Combination of Business with GENETRIX’ subsidiary X-Pol
Finanzkalender
-
Mar 28, 2013:
Financial Report short fiscal year 2012
-
May 15, 2013:
Financial Report Q1 (January 1st - March 31, 2013)
-
Aug 14, 2013:
Financial Report Q2 (April 1st - June 30, 2013)
-
Nov 14, 2013:
Financial Report Q3 (July 1st - September 30, 2013)